Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Timing of intermittent seminal HIV-1 RNA shedding in patients with undetectable plasma viral load under combination antiretroviral therapy.
Ferraretto X, Estellat C, Damond F, Longuet P, Epelboin S, Demailly P, Yazbeck C, Llabador MA, Pasquet B, Yazdanpanah Y, Matheron S, Patrat C. Ferraretto X, et al. Among authors: matheron s. PLoS One. 2014 Mar 3;9(3):e88922. doi: 10.1371/journal.pone.0088922. eCollection 2014. PLoS One. 2014. PMID: 24594873 Free PMC article.
French 2013 guidelines for antiretroviral therapy of HIV-1 infection in adults.
Hoen B, Bonnet F, Delaugerre C, Delobel P, Goujard C, L'Hénaff M, Persiaux R, Rey D, Rouzioux C, Taburet AM, Morlat P; 2013 French HIV expert group. Hoen B, et al. J Int AIDS Soc. 2014 Jun 17;17(1):19034. doi: 10.7448/IAS.17.1.19034. eCollection 2014. J Int AIDS Soc. 2014. PMID: 24942364 Free PMC article.
Ebola: should we consider influenza vaccination?
Matheron S, Baize S, Lerat I, Houhou N, Yazdanpanah Y. Matheron S, et al. Lancet. 2014 Dec 6;384(9959):2023-4. doi: 10.1016/S0140-6736(14)62226-1. Epub 2014 Nov 19. Lancet. 2014. PMID: 25467571 No abstract available.
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.
Lê MP, Mandelbrot L, Descamps D, Soulié C, Ichou H, Bourgeois-Moine A, Damond F, Lariven S, Valantin MA, Landman R, Faucher P, Tubiana R, Duro D, Meier F, Legac S, Bourse P, Mortier E, Dommergues M, Calvez V, Matheron S, Peytavin G. Lê MP, et al. Among authors: matheron s. Antivir Ther. 2015;20(5):507-13. doi: 10.3851/IMP2936. Epub 2015 Jan 20. Antivir Ther. 2015. PMID: 25599649
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S; ANRS-EPF Study Group. Mandelbrot L, et al. Among authors: matheron s. Clin Infect Dis. 2015 Dec 1;61(11):1715-25. doi: 10.1093/cid/civ578. Epub 2015 Jul 21. Clin Infect Dis. 2015. PMID: 26197844
365 results